Company intelligence / Profile preview
Akttyva Therapeutics
Watertown, Massachusetts, United Statesakttyva.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Akttyva Therapeutics is developing small molecule therapeutics to repair vascular leak, with its lead program in advanced preclinical studies targeting ARDS. The company’s AI-driven AIDE-360 platform has identified novel candidates and received recognition from the National Science Foundation and IBM. No clinical results have been reported yet; programs are currently at the preclinical validation stage.
- Therapeutic areas
- PulmonologyCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
IBMNational Science Foundation
Beyond the preview
Go deeper on Akttyva Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akttyva Therapeutics.